에 대한 최신 뉴스 Castellum (AMEX:CTM) 주식

Castellum

Castellum Inc is engaged in providing information technology services. The company provides financial services, healthcare, and other users of large data applications with services that include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and MBSE. In addition to constantly innovating and enhancing organic capabilities, Castellum is acquiring technology companies in the areas of cybersecurity, information technology, electronic warfare, information warfare, and information operations with businesses in the defense, federal, civilian, and commercial markets.

Medtronic, Fluor And 3 Stocks To Watch Heading Into Tuesday

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

CWCO

GETY

SAIC

월요일(17일) 아침 미국 지수 선물이 하락세를 보이고 있는 가운데, 오늘 투자자 관심을 끌 수 있는 주식은 다음과 같다. 사이언스 어플리케이션, 게티 이미지, 카스텔럼, 콘솔리테이티드 워터 및 타운스퀘어

월요일 주목해야 할 주식: 사이언스 어플리케이션, 게티 이미지, 카스텔럼, 콘솔리테이티드 워터 및 타운스퀘어

Castellum Inc

CANTERRA MINERALS CORP by Canterra Minerals Corp.

Canterra Minerals Corp

CORPORATE TRAVEL MGMT LTD by Corporate Travel Management Ltd

Corporate Travel Management Ltd

CytomX Therapeutics Inc

ETON

Eton Pharmaceuticals Q4 2024 GAAP EPS $(0.02) Vs. $(0.09) YoY, Sales $11.65M Beat $10.53M Estimate

Guidance

CTRN

Citi Trends Sees FY25 Comparable Store Sales Growth Of Low To Mid-Single Digits

Citi Trends (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTRN#NASDAQ">CTRN</a>) reported quarterly losses of $(1.71) per share which missed the analyst consensus estimate of $0.18 by 1050 percent. This is a 422.64 percent decrease over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $211.17 million which missed the analyst consensus estimate of $211.54 million by 0.17 percent. This is a 1.86 percent decrease over sales of $215.18 million the same period last year.

Earnings Misses

Citi Trends Q4 Adj $(1.71) Misses $0.18 Estimate, Sales $211.17M Miss $211.54M Estimate

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Sana Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANA#NASDAQ">SANA</a>) with a Buy and maintains $11 price target.

Price Target

Reiteration

Analyst Ratings

SANA

HC Wainwright & Co. Reiterates Buy on Sana Biotechnology, Maintains $11 Price Target

NIO Inc.(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>)&nbsp;shares are trading <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">higher in the premarket </a>session on Tuesday.
NIO and Contemporary Amperex Technology Co., Ltd. (CATL) have <a target="_blank" href="https://www.nio.com/news/20250318001" rel="noreferrer noopener">joined </a>forces to enhance the development of the new energy vehicle sector.
On Monday, the companies announced a strategic partnership to establish a comprehensive battery swapping network for passenger vehicles, optimize industry standards, and provide efficient recharging solutions.
William Li, founder and CEO of NIO, and Dr. Robin Zeng, chairman and CEO of CATL, were both present at the signing ceremony, marking the beginning of this major strategic venture.
NIO has established a vast network of charging and battery swapping stations across China, surpassing 3,000 Power Swap Stations.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/25/03/44359600/hyperfine-nvidia-partner-to-make-brain-mris-more-affordable" rel="noreferrer noopener">Hyperfine, Nvidia Partner To Make Brain MRIs More Affordable</a>
The company aims to expand this network considerably by 2025, reaching additional cities and county-level areas.
In March 2024, NIO and CATL inked a framework agreement to promote innovation in the R&amp;D of long-life batteries jointly.
&#8220;The strategic cooperation between NIO and CATL marks a pivotal moment, propelling battery swapping into a brand-new phase,&#8221; said Li.
CATL&#8217;s investment of up to RMB 2.5 billion (~$346 million) in NIO Power will strengthen this strategic partnership. CATL will assist NIO in enhancing its battery-swapping network. Additionally, they will collaborate to establish national standards for battery-swapping technology in China, which will improve compatibility among various brands.
&#8220;Leveraging our Choco-Swap and the parallel operations of both CATL&#8217;s and NIO&#8217;s networks, we are able to build a smart power network that caters to a wide range of needs across multiple levels and dimensions. This will enable every battery to deliver greater value throughout its lifecycle, and allow us to provide global users with safer, more efficient, and more sustainable electric mobility solutions,&#8221; said Zeng.
NIO will report its fourth quarter&nbsp;results on Friday, March 21, 2025, before the open of the U.S. markets.
Price Action: NIO shares traded higher by 5.77% at $5.32 in premarket at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/03/44358047/pepsico-bets-big-on-prebiotic-sodas-with-1-95-billion-poppi-acquisition-details" target="_blank" rel="noreferrer noopener">PepsiCo Bets Big On Prebiotic Sodas With $1.95 Billion Poppi Acquisition: Details</a></li>
</ul>
Photo by Sundry Photography on Shutterstock.

Equities

Contracts

Movers

What's Going On With NIO Stock Today?

B of A Securities analyst Julien Dumoulin-Smith maintains American Electric Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEP#NASDAQ">AEP</a>) with a Buy and raises the price target from $108 to $114.

B of A Securities Maintains Buy on American Electric Power, Raises Price Target to $114

B of A Securities analyst Allen Lutz maintains Hims &amp; Hers Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) with a Underperform and raises the price target from $21 to $22.

Hims & Hers Health, Inc. Class A Common Stock

HIMS

B of A Securities Maintains Underperform on Hims & Hers Health, Raises Price Target to $22

HC Wainwright &amp; Co. analyst Yi Chen reiterates Belite Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLTE#NASDAQ">BLTE</a>) with a Buy and maintains $100 price target.

BLTE

HC Wainwright & Co. Reiterates Buy on Belite Bio, Maintains $100 Price Target

BBAI

BigBear.ai Estimates Restatement To Change 2023 Income Before Taxes To $(71.3)M From Prior $(60.3)M, To Change 2024 Income Before Taxes To $(296.1)M From Prior $(257.1)M

General

VIAV

VIAVI Launches 800G Module Expanding Portfolio Of High-Speed Test Solutions

Carter's Launches Spring Break Collection Curated By Social Media Star Baby Kate

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Gossamer Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOSS#NASDAQ">GOSS</a>) with a Buy and maintains $10 price target.

GOSS

HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target

BigBear.ai Identifies Need To Restate Certain Prior Financial Statements - Filing

Health Care

CMPS

Compass Pathways Publishes Results From COMP360 Psilocybin Study Indicating Longer-Term antidepressant Effects With 25mg Dose

This LOI builds on the existing Development Service Agreement between Solterra and SB Impact 4, which granted exclusivity to SB Impact 4 and N2OFF for evaluating and potentially acquiring these projects within a 60-day period.

NITO

N2OFF Signs Non-binding Letter Of Intent With SB Impact 4 And Solterra Brand Services Italy

Needham analyst Mike Matson maintains Haemonetics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAE#NYSE">HAE</a>) with a Buy and lowers the price target from $108 to $104.

Needham Maintains Buy on Haemonetics, Lowers Price Target to $104

OUST

Ouster Launches Cloud Portal For Ouster Gemini

Morgan Stanley analyst Adam Jonas upgrades Lucid Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) from Underweight to Equal-Weight and announces $3 price target.

Upgrades

LCID

Morgan Stanley Upgrades Lucid Group to Equal-Weight, Announces $3 Price Target

ITT Launches Industrial Smart Motor VIDAR That Reduces Operating Costs And Cuts Co2 Emissions

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Altimmune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) with a Buy and maintains $12 price target.

HC Wainwright & Co. Reiterates Buy on Altimmune, Maintains $12 Price Target

Press Releases

Castellum Announces Pricing of $3.7 Million Public Offering of Common Stock

Castellum, Inc.'s SBA Protégés Successfully Onboard to SeaPort-NxG Contract

Castellum Announces the Award of a $3.2 million Contract to its Specialty Systems, Inc. Subsidiary

Castellum, Inc. Announces Its GTMR Subsidiary Has Been Selected as a SCI MAC Vendor

Castellum, Inc. Announces 2024 Unaudited Financial Results

Castellum, Inc. Announces the Award of a $103.3 million Contract to its GTMR Subsidiary

Management

Castellum, Inc. Hires Tanya Bassett as Vice President of Business Development and Capture Management; Reinforces Strategic Commitment to Organic Growth

Castellum Announces Proposed Public Offering of Common Stock and Warrants

Castellum Announces Pricing of $4.5 Million Public Offering of Common Stock and Warrants

Castellum, Inc.'s Subsidiary GTMR Achieves CMMI Level 3 Appraisal

Accenture plc Class A Ordinary Shares (Ireland)

Accenture

ASGN

Alpha Technology Group Limited - Class A Ordinary Shares

Alpha Technology Group

BigBear.ai Hldgs

CI&T

Cognizant Technology Solutions Corporation - Class A Common Stock

Cognizant Tech Solns

Endava plc American Depositary Shares (each representing one Class A Ordinary Share)

Endava

DXC Technology

EPAM Systems

Grid Dynamics Holdings, Inc. - Class A Common Stock

Grid Dynamics Holdings

Globant

Hackett Group

International Business Machines Corporation Common Stock

Information Services Group, Inc. - Common Stock

Information Servs Gr

Infosys Limited American Depositary Shares

Infosys

Gartner

Kyndryl Hldgs

MicroAlgo

Research Solutions

Trident Digital Tech Holdings Ltd - American Depository Shares

Trident Digital Tech

Unisys

Wipro

Youxin Technology Ltd - Class A Ordinary shares

Youxin Technology

EF Hutton

월요일(17일) 아침 미국 지수 선물이 하락세를 보이고 있는 가운데, 오늘 투자자 관심을 끌 수 있는 주식은 다음과 같다.
<ul>
<li>사이언스 어플리케이션스 인터내셔널 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>): 월요일 개장 전 실적을 발표할 예정이며, 분기 실적을 주당 2.08달러, 매출 18억 1,000만 달러로 예상하고 있다. <a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noopener">Benzinga Pro </a>데이터에 따르면 지난 금요일 주가는 0.2% 상승하여 104.43달러로 마감했다.</li>
<li>게티 이미지(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GETY#NYSE">GETY</a>): 월요일 장 마감 후 실적을 발표할 예정이며, 분기 실적을 주당 4센트, 매출 2억 4,631만 달러로 예상하고 있다. 지난 금요일 주가는 2% 상승하여 2.04달러로 마감했다.</li>
<li>카스텔럼(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTM#NYSE">CTM</a>)은 보통주와 워런트의 공모를 제안했다. 금요일 애프터마켓에서 22.03% 하락하여 0.92달러에 거래되었다.</li>
</ul>
자세한 내용은 <a href="https://www.benzinga.com/premarket/" target="_blank" rel="noopener">프리마켓 보도</a>를 확인하세요.
<ul>
<li>콘솔리데이티드 워터(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWCO#NASDAQ">CWCO</a>): 분기 실적을 주당 28센트, 매출 3,360만 달러로 예상하고 있다. 금요일에 주식은 2.8% 상승하여 29.18달러로 마감했다.</li>
<li>다운스퀘어 미디어 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSQ#NYSE">TSQ</a>): 월요일 개장 전 실적을 발표할 예정이며, 분기 실적은 주당 60센트, 매출 1억 1,641만 달러로 예상한다. 주가는 지난 금요일 애프터마켓에서 1.9% 상승하여 7.94달러에 거래되었다.</li>
</ul>
사진 제공: Shutterstock
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Castellum

뉴스

에 대한 최신 뉴스 Castellum (AMEX:CTM) 주식

월요일, 3월 17, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌